Deletion of the glucagon receptor gene before and after experimental diabetes reveals differential protection from hyperglycemia
Objective: Mice with congenital loss of the glucagon receptor gene (Gcgr−/− mice) remain normoglycemic in insulinopenic conditions, suggesting that unopposed glucagon action is the driving force for hyperglycemia in Type-1 Diabetes Mellitus (T1DM). However, chronic loss of GCGR results in a neomorph...
Main Authors: | Belen Rivero-Gutierrez, April Haller, Jenna Holland, Emily Yates, Radha Khrisna, Kirk Habegger, Richard Dimarchi, David D'Alessio, Diego Perez-Tilve |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-11-01
|
Series: | Molecular Metabolism |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2212877818306495 |
Similar Items
-
Revisiting the Pharmacological Value of Glucagon: An Editorial for the Special Issue “The Biology and Pharmacology of Glucagon”
by: Timo D. Müller, et al.
Published: (2020-01-01) -
Glucagon Regulation of Energy Expenditure
by: Maximilian Kleinert, et al.
Published: (2019-10-01) -
Berberine Attenuates Hyperglycemia by Inhibiting the Hepatic Glucagon Pathway in Diabetic Mice
by: Ying Zhong, et al.
Published: (2020-01-01) -
Glucagon-like peptide 1 (GLP-1)
by: T.D. Müller, et al.
Published: (2019-12-01) -
Deletion of the CPR gene prevent streptozotocin-induced hyperglycemia in mice
by: Tzu-Yi Hu, et al.
Published: (2014)